ArticleEye (London, England)2015
Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.
G A Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it